IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
CBD
From:
Sylvia Caras <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Sat, 24 Feb 2018 08:54:44 -0800
Content-Type:
text/plain
Parts/Attachments:
text/plain (13 lines) 
6 weeks of treatment with CBD in adjunct to antipsychotics was 
associated with signi cant effects both on positive psychotic 
symptoms and on the treating clinicians' impressions of improvement 
and illness severity, although effects were modest.

CBD may represent a new class of treatment for schizophrena.

http://www.psychiatrictimes.com/schizophrenia/adjunctive-cannabidiol-therapy-schizophrenia?rememberme=1&elq_mid=395&elq_cid=1800132&GUID=F48441FB-F00E-4646-A1C2-3BD6BC983692



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2